|1.||Cynober, Luc: 2 articles (10/2007 - 06/2005)|
|2.||Coudray-Lucas, C: 2 articles (03/2007 - 06/2000)|
|3.||Cynober, L: 2 articles (03/2007 - 06/2000)|
|4.||Gonçalves, Eduardo Silvio Gouveia: 1 article (01/2011)|
|5.||Garcia, José Huygens Parente: 1 article (01/2011)|
|6.||Guimarães, Sérgio Botelho: 1 article (01/2011)|
|7.||Rabelo, Camila Menezes: 1 article (01/2011)|
|8.||Prado Neto, Alberico Ximenes do: 1 article (01/2011)|
|9.||Vasconcelos, Paulo Roberto Leitão de: 1 article (01/2011)|
|10.||Walrand, S: 1 article (08/2010)|
10/01/1999 - "Nutritional and clinical efficacy of ornithine alpha-ketoglutarate in severe burn patients."
06/01/2000 - "Previous clinical and experimental studies suggest a beneficial effect of enterally administered ornithine alpha-ketoglutarate supplementation on protein metabolism in burn patients, but few data deal with clinical outcome. "
06/01/2000 - "Ornithine alpha-ketoglutarate improves wound healing in severe burn patients: a prospective randomized double-blind trial versus isonitrogenous controls."
06/01/2000 - "In addition, ornithine alpha-ketoglutarate administration was safe and well tolerated and decreased protein hypercatabolism in the less severe burn patients."
10/01/1999 - "In this prospective, randomized and double-blind study, 60 patients who had undergone severe burns (20-60% of body surface area) received either ornithine alpha-ketoglutarate (20 g/day) or an isocaloric placebo, for 21 days, starting mean 4 days after injury. "
|2.||Critical Illness (Critically Ill)
11/01/1998 - "Ornithine alpha-ketoglutarate (OKG) has been advocated in the treatment of critically ill patients for its anabolic effect on protein metabolism. "
06/01/2003 - "While, amino acid mixtures of glutamine dipeptides, ornithine alpha-ketoglutarate, asparagine, oxaloacetate, arginine, aspartate and glutamate have been used in a variety of conditions, prospective randomised controlled trials have not consistently demonstrated improved survival with their use in the critically ill patient. "
01/01/1982 - "[Use of ornithine alpha-ketoglutarate in malnourished cancer patients]."
12/01/1995 - "Compared with glycine, ornithine alpha-ketoglutarate had no effect on tumor growth, but also did not alter the catabolic effects of the tumor on its host. "
12/01/1995 - "Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support."
07/01/1994 - "Ornithine alpha-ketoglutarate limits muscle protein breakdown without stimulating tumor growth in rats bearing Yoshida ascites hepatoma."
12/01/1999 - "Dietary supplementation with glutamine (Gln), arginine (Arg) or ornithine 2-oxoglutarate (alpha-ketoglutarate; OKG) has attracted recent attention for the potential to improve anti-cancer immune function. "
05/01/1978 - "A double blind controlled trial of ornithine alpha-ketoglutarate (OAKG) was carried out on 50 patients admitted to the Royal Free and Royal Northern Hospitals, London, suffering from a recent stroke. "
05/01/1978 - "Controlled trial of ornithine alpha ketoglutarate (OAKG) in patients with stroke."
|3.||Glutamic Acid (Glutamate)
|8.||alpha-ketoglutaric acid (alpha-ketoglutarate)
|1.||Nutritional Support (Artificial Feeding)
|2.||Enteral Nutrition (Feeding, Tube)
|3.||Total Parenteral Nutrition